Waltham, United States
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development and types of financing rounds.
34
Total Investments
25
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Agent Capital
Recent Investments (34)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | May 2025 | |
| Series A | •••••• | Jan 2025 | |
| Early VC | •••••• | Nov 2024 | |
| Series B | •••••• | Nov 2024 | |
| Series B | •••••• | Jul 2024 | |
•••• ••••
|
Series B | •••••• | Apr 2024 |
|
•••• ••••
|
Post Ipo Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Series B | •••••• | Nov 2023 |
|
•••• ••••
|
IPO | •••••• | Nov 2023 |
|
•••• ••••
|
Early VC | •••••• | Nov 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
